Stage IVB Colorectal Cancer Active Not Recruiting Phase 2 Trials for Bevacizumab (DB00112)

DBCOND0068497 (Stage IVB Colorectal Cancer)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT02292758Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryTreatment
NCT02873195Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal CancerTreatment